Petition for Reclassification of next-generation sequencing oncology panels used for somatic or germline variant detection that include one or more companion diagnostic indications from class III to class II
🏛 Food and Drug Administration (FDA)FDA-2024-P-3484
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.